NCT00909610View on ClinicalTrials.gov

Ursodiol Tablets 500 mg Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Healthy
Interventions
DRUG

Ursodiol

Ursodiol Tablets, 500 mg

DRUG

Urso Forte™

Urso Forte™ Tablets, 500 mg

Trial Locations (1)

M1R 5A3

Pharma Medica Research Inc., Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00909610 - Ursodiol Tablets 500 mg Under Fasting Conditions | Biotech Hunter | Biotech Hunter